J. Wouter Jukema is professor of (interventional) cardiology with special focus on atherothrombosis and regenerative medicine. He is a past “Established Clinical Investigator” of the Netherlands Heart Foundation and founding director of the Durrer Center for Cardiogenetic Research in Amsterdam. Currently he is also chairman of “Leiden Vascular Medicine” as well as co-chairman of the Dutch Atherosclerosis Society. Prof. Jukema is principal investigator of many major interventional/athero-thrombosis studies, a member of various national and international athero-thrombosis boards and holder of multiple major (a.o. European Union) grants.

Contributions

Which patient needs the PCSK9 inhibitors most?89th EAS Congress 2021(Anti PCSK9ReviewTreatmentCholesterolHypolipidemic drugs)A deep look to the results of Odyssey outcomes87th EAS Congress 2019The ideal patient for PCSK986th EAS Congress 2018